Chongqing Lummy Pharmaceutical Co., Ltd.

DNA topoisomerase inhibitors prevent bacterial DNA from forming supercoiled structures, causing bacterial cells to be unable to divide and proliferate and die.

This product is a fourth-generation quinolone antibacterial drug. Its mechanism of action is a DNA topoisomerase inhibitor, which prevents bacterial DNA from forming a supercoiled structure, causing bacterial cells to be unable to divide and proliferate and die.

No specific description provided

1. It has a strong antipyretic effect on rabbits with fever caused by bacterial endotoxins, and the effect is rapid and can last for more than 4 hours; 2. It can counteract the increased permeability of capillary walls caused by xylene or histamine, and has a significant antagonistic effect on adrenaline-induced acute pulmonary edema; 3. It can shorten the sleep latency of mice caused by sodium pentobarbital, prolong their sleep time, and strengthen the subthreshold effect of sodium pentobarbital to induce sleep in mice, indicating a significant sedative effect; 4. It can significantly promote the adrenal cortex function of rats and increase the body's emergency response to pathogen infection; 5. It has an inactivation effect on influenza virus type AⅠ, type AⅢ, pneumonia adenovirus (Adv) type III, type IV, enterosyncytial virus and respiratory syncytial virus (RSV).

Azithromycin inhibits the synthesis of bacterial proteins through the bacterial transpeptidation process. It has antibacterial effects on a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms.